- Membership Level
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 5,400+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
BeiGene: Blood Cancer Has No Borders, Neither Do We: https://youtu.be/UUoKZYigazk
Click the link to view BeiGene’s activities and presentations presented this year during the 25th European Hematology Association (EHA) Virtual Congress that took place on June 11-14. http://ir.beigene.com/news-